3-Oxo-4-(?D-ribofuranosyl)-3,4-dihydro-2-pyrazinecarboxamide structure
|
Common Name | 3-Oxo-4-(?D-ribofuranosyl)-3,4-dihydro-2-pyrazinecarboxamide | ||
|---|---|---|---|---|
| CAS Number | 356782-84-8 | Molecular Weight | 271.23 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C10H13N3O6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 3-Oxo-4-(?D-ribofuranosyl)-3,4-dihydro-2-pyrazinecarboxamide3,4-Dihydro-3-oxo-4-β-D-ribofuranosyl-2-pyrazinecarboxamide is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 3,4-dihydro-3-oxo-4-β-D-ribofuranosyl-2-pyrazinecarboxaMide |
|---|
| Description | 3,4-Dihydro-3-oxo-4-β-D-ribofuranosyl-2-pyrazinecarboxamide is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C10H13N3O6 |
|---|---|
| Molecular Weight | 271.23 |
| InChIKey | XVXWUBIIHFDOJO-KQYNXXCUSA-N |
| SMILES | NC(=O)c1nccn(C2OC(CO)C(O)C2O)c1=O |